Key Insights

Highlights

Success Rate

92% trial completion (above average)

Published Results

213 trials with published results (24%)

Research Maturity

529 completed trials (59% of total)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

4.8%

43 terminated out of 904 trials

Success Rate

92.5%

+5.9% vs benchmark

Late-Stage Pipeline

25%

229 trials in Phase 3/4

Results Transparency

40%

213 of 529 completed with results

Key Signals

213 with results92% success43 terminated

Data Visualizations

Phase Distribution

697Total
Not Applicable (321)
Early P 1 (4)
P 1 (58)
P 2 (85)
P 3 (131)
P 4 (98)

Trial Status

Completed529
Recruiting104
Unknown94
Not Yet Recruiting51
Terminated43
Active Not Recruiting30

Trial Success Rate

92.5%

Benchmark: 86.6%

Based on 529 completed trials

Clinical Trials (904)

Showing 20 of 20 trials
NCT05669703Recruiting

NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar Disorder

NCT07616128Phase 2RecruitingPrimary

Study of EVO756 in Adults With Migraine

NCT07856056Phase 4Not Yet RecruitingPrimary

Nortriptyline Compared With Amitriptyline for Migraine Prevention at SQUH

NCT07567300Recruiting

Common Pain Mechanisms in Migraine, Migraine-Related Neck Pain, and Lower Back Pain: A Cross Sectional Study

NCT07554664CompletedPrimary

Central Sensitization, Work-Related Stress, and Musculoskeletal Symptoms in Desk-Based Workers With and Without Migraine

NCT06428838Phase 3Enrolling By InvitationPrimary

Eptinezumab as an Adjunct to Standard of Care for Migraine in an Acute Emergency Context

NCT07850622Not ApplicableCompletedPrimary

High-Intensity Interval Training and Progressive Muscle Relaxation as a Movement-Based Group Intervention for the Non-Pharmacological Prevention of Adolescent Migraine: A Controlled Pilot Study

NCT07847554Not Yet RecruitingPrimary

Validity and Reliability of the Greek WPAI:Migraine

NCT07847528Not Yet RecruitingPrimary

Validity and Reliability of the Greek Pain Catastrophizing Scale

NCT05156398Phase 3RecruitingPrimary

Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

NCT07843745Not Yet RecruitingPrimary

Assessment of Head Awareness in Patients With Migraine in the Greek Population

NCT07546201Not Yet RecruitingPrimary

Investigation of Imagery Abilities in Individuals With Migraine

NCT06459648Active Not RecruitingPrimary

Study for Prevent Chronification Migraine Through Prediction of Response to Treatment With Anti-CGRP Antibodies

NCT07841509Not ApplicableRecruitingPrimary

The Effect of Remote Electrical Neuromodulation (REN) on Conditioned Pain Modulation (CPM) in Migraine and Fibromyalgia

NCT07824661Not ApplicableCompletedPrimary

Impact of Cessation of Toothpaste in Patients With Migraine Headaches

NCT06848075Phase 2CompletedPrimary

A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine

NCT04567355Phase 2CompletedPrimary

Migraine Manager (R01)

NCT06473597Phase 4RecruitingPrimary

A Comparison of Nurtec ODT to Maxalt MLT-ODT in Adult ED Patients With Migraine Headache

NCT05112289Not ApplicableActive Not RecruitingPrimary

A Study to Evaluate White Matter Hyperintensities in Migraine

NCT07419607Not ApplicableCompletedPrimary

MIGRAFIT: Evaluating a Group Therapy Program Combining Physical Activity, Progressive Muscle Relaxation and Psychoeducation for Adolescents With Migraine

Scroll to load more

Research Network

Activity Timeline